[BioC] Question about best analysis method for a complex array expriment design
Agnes Paquet
paquet at ipmc.cnrs.fr
Wed Jan 8 11:45:41 CET 2014
Dear List,
I need to analyze an experiment with a design more complex than usual
for our facility, and I am not sure about the best way to analyze this
dataset. I would really appreciate your advice on whether the method I
am planning to use is correct, or if there is a better way to analyze
this data.
The experiment design is the following:
We have 10 patients, and we are using one-color Agilent arrays. Each
patient performed a physical test twice: once without anything added,
and once taking a drug during the test. Samples are collected before and
after the physical test, for a total of 4 samples by patients. The drug
was administered randomly during the first or second test.
Here is the top of my target file:
Patient.ID TimePoint Drug TestOrder Drug.Included.In.Test
Pt1 Before no test1 control
Pt1 After no test1 control
Pt1 Before no test2 test
Pt1 After yes test2 test
Pt2 Before no test2 control
Pt2 After no test2 control
Pt2 Before no test1 test
Pt2 After yes test1 test
We are interested in finding:
- DE genes related to physical test only
- DE genes related to the addition of the drug only
- Genes differentially regulated by the drug during the physical test
I usually use limma for differential analysis, so following the limma
user’s guide, I was planning to use a design with blocks of size 4 for
patients, and a variable with 4 levels combining Drug.Included.In.Test
and TimePoint.
Is this approach correct?
I read in the user’s guide patient information could also be modeled as
random effect using the duplicateCorrelation function. Would this method
be more appropriate?
Is there a better way to model the data, that would estimate the
physical test effect and the drug effect directly?
Thank you very much for your help,
Agnes
More information about the Bioconductor
mailing list